TORONTO (AP) — TORONTO (AP) — COSCIENS Biopharma Inc. (CSCIF) on Tuesday reported earnings of $10.8 million in its first quarter.
The Toronto-based company said it had profit of $2.90 per share. Losses, adjusted to account for discontinued operations, were 6 cents per share.
The drug developer posted revenue of $1.9 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CSCIF at https://www.zacks.com/ap/CSCIF
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
